Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT02834260
Eligibility Criteria:
Inclusion Criteria:
* Keratoconus
* Fuch's dystrophy
* Hereditary stromal dystrophy
* Age 18 years old and more
* Signed informed consent
* Affiliated to the French Social Security
Exclusion Criteria:
* Hypersensitivity to Dexamethasone or the excipients (polylactic and glycolic acid)
* Active ocular or periocular infection
* Advanced glaucoma
* History of herpetic or zoster keratitis
* Retinal disease for which an intravitreal injection of Ozurdex is planed for the next 3-4 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02834260
Study Brief:
Protocol Section:
NCT02834260